Home > Boards > US OTC > Cannabis >

Emerald Bioscience Inc. (EMBI)

EMBI RSS Feed
Add EMBI Price Alert      Hide Sticky   Hide Intro
Moderator: Southern Gal, StockRocket, captainscotty, Scout72
Search This Board: 
Last Post: 1/21/2020 11:01:18 AM - Followers: 130 - Board type: Free - Posts Today: 0










 

 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:  http://www.nemusbioscience.com/home.html

Filings and disclosure with Level 2 quotes:  http://www.otcmarkets.com/stock/NMUS/quote

Contact:

(949) 396-0330
E-MAIL: BRIAN@NEMUSBIO.COM
600 ANTON BLVD, SUITE 1100, COSTA MESA, CA 92626


 

Nemus Bioscience (NMUS) Presentation (47 minutes):  
https://www.youtube.com/watch?v=tYV2PEaj6os

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016: 
http://s2.q4cdn.com/753474459/files/doc_presentations/2016/Rodman-Conf-September-2016_FINAL.pdf

















https://www.emeraldbio.life/about-1












Emerald Bioscience is a biopharmaceutical company focused on the discovery, development and commercialization of new chemical entities from a class of chemically diverse compounds called cannabinoids. These molecules display pleiotropic activity by virtue of selectively binding to two types of cannabinoid receptors (CB1 and CB2) located throughout multiple organ systems in the body. Currently, Emerald Bioscience is developing a novel and proprietary class of product candidates that are designed to improve therapeutic options based on chemical engineering that allow drug candidates to have enhanced bioavailability and more predictable pharmacokinetics, leading to optimized efficacy and safety.







https://www.otcmarkets.com/stock/EMBI/news




 


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  
 

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -


Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy


Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)

 

Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model

 

Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.


NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 


CANNAINVESTOR Magazine Top 20 Cannabis Stocks 

 

NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 

 

NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 

 

NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 

 

Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 

 

NMUS Security Details

Share Structure - as of Feb 1, 2017
Source: otcmarkets.com

Authorized Shares: 236,000,000
Outstanding Shares: 132,414,079 a/o April 18, 2018

      - Restricted  90,689,442
    - Unrestricted  41,724,637

           - Float  14,218,313 a/o April 18, 2018 
   Par Value 0.001


Transfer Agent: Clear Trust, LLC 






 








 
 
 
EMBI
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
EMBI News: Post-effective Amendment to Registration Statement (pos Am) 05:17 PM
EMBI News: Notice of Effectiveness (effect) 01/02/2020 06:00:59 AM
EMBI News: Current Report Filing (8-k) 12/23/2019 06:01:21 AM
EMBI News: Withdrawal of Registration Statement (ammendment) (aw) 12/17/2019 06:03:09 AM
EMBI News: Post-effective Amendment to Registration Statement (pos Am) 12/09/2019 05:24:30 PM
News News Alert: Post-effective Amendment to Registration Statement (pos Am) 01/22/2020 05:17:24 PM
PostSubject
#5788  Sticky Note #EMBI:Emerald.Bioscience.Announces.$2.0.Million.Registered.Direct.Offering...:-} captainscotty 11/25/19 09:31:21 AM
#5742  Sticky Note Great DD Document--This why we are here! Scout72 09/16/19 02:10:29 PM
#5836   Added 10k today ty. StockRocket 01/21/20 11:01:18 AM
#5835   what became of financing deal at .25 with Mandofellow 01/21/20 10:55:59 AM
#5834   interesting StockRocket 01/18/20 07:40:16 PM
#5833   Reposting this article. The IP they own and frozenspokes 01/18/20 11:03:31 AM
#5832   I expect some bigger pharma company to take StockRocket 01/16/20 09:09:38 AM
#5831   Been accumulating at these prices.....ty StockRocket 01/14/20 06:08:34 AM
#5830   Added a few here. StockRocket 01/10/20 09:48:46 AM
#5829   Good article. May move $ from pos iml() HorizenBull 01/07/20 04:24:09 PM
#5828   Added a few the last week...love the price. StockRocket 01/07/20 10:29:42 AM
#5827   Right now it’s an eye drop and it Vinpat 01/07/20 01:53:31 AM
#5826   What’s the delivery mechanism for THC into the eye? HorizenBull 01/07/20 12:26:41 AM
#5825   Looking to reload here....stock price undervalued. StockRocket 01/03/20 09:41:31 AM
#5824   Yep. This should be sitting at .30 while Vinpat 01/02/20 06:07:42 PM
#5823   Yeah I grabbed some Jdanger 2 01/02/20 04:46:41 PM
#5822   Anyone buying at these prices? Romes14 01/02/20 11:58:16 AM
#5821   ...how soon before the club runs this over Mandofellow 01/02/20 10:00:55 AM
#5820   Súper oversold. Only an idiot would sell at Impacto 12/31/19 12:00:25 PM
#5819   Not looking good!!! Lmfao!!! dnoto 12/31/19 11:51:40 AM
#5818   Parent company EMH exercised 40m warrants per a Jdanger 2 12/31/19 11:07:54 AM
#5817   Buying !!! Impacto 12/31/19 10:07:52 AM
#5816   What the heck is going on with EMBI? zoom22 12/31/19 09:54:01 AM
#5815   http://www.stockta.com/cgi-bin/analysis.pl?symb=embi&table=rsi&mode=table Southern Gal 12/31/19 09:18:46 AM
#5814   what happened? just broke all time lows dary4321 12/30/19 03:56:42 PM
#5813   Nice to see you're still here, Vinpat. I Jdanger 2 12/27/19 04:56:11 PM
#5812   There’s no good reason to do a reverse Vinpat 12/27/19 12:25:16 AM
#5811   Reducing debt and warrant liability is good (minus mmjbuyer 12/26/19 05:39:49 PM
#5810   #EMBI: KOOL bring it on...:-} 0.10 captainscotty 12/26/19 12:32:06 PM
#5809   did everyone that was here sell at a Mandofellow 12/26/19 10:28:53 AM
#5808   Timber!!! This one is going down more dnoto 12/24/19 02:03:34 PM
#5807   Looks like they elected the $.10 warrants and mmjbuyer 12/23/19 08:27:24 AM
#5806   what is meaning of last 2 news items Mandofellow 12/17/19 03:53:07 PM
#5805   My guess is that there is Tax loss Romes14 12/17/19 02:56:59 PM
#5804   is the current offering still open..?...is it trying Mandofellow 12/17/19 11:21:16 AM
#5803   thanks for posting that...a bit too mysterious here Mandofellow 12/13/19 01:29:53 PM
#5802   Mid 2020 for human trials.. Amino505b2 12/13/19 10:45:51 AM
#5801   #EMBI: Emerald Bioscience Inc. Announces Cannabidiol-Valine-Hemisuccinate Possesses Enhanced captainscotty 12/11/19 08:46:47 AM
#5800   #EMBI : https://www.emeraldbio.life/ captainscotty 12/11/19 08:44:16 AM
#5799   I wonder if the "certain investors" are looking Southern Gal 12/05/19 05:05:45 PM
#5798   if i buy this .21 or so...for sure Mandofellow 12/04/19 12:47:28 PM
#5797   Emerald Health (parent group) is on brink of mmjbuyer 12/04/19 11:35:30 AM
#5796   I'm buying today Southern Gal 12/04/19 11:12:58 AM
#5795   offering said to be closed on or around Mandofellow 12/04/19 09:54:19 AM
#5794   sounds good...wonder when offering will close...hard to sell Mandofellow 11/29/19 11:12:53 AM
#5793   Picked up 50,000 between .215 and .219 Southern Gal 11/27/19 03:31:20 PM
#5792   http://archive.fast-edgar.com//20191126/AVZ222ZZZBQZWIZZZ52FZZZZNEPWVZERZ2Z2/fil Mandofellow 11/27/19 11:18:52 AM
#5791   i was hoping it was in regards to Mandofellow 11/27/19 10:53:03 AM
#5790   that's an error on the blog i believe mmjbuyer 11/27/19 10:16:54 AM
#5789   what does sec want...?...surprised no one talking here... Mandofellow 11/27/19 10:10:38 AM
#5788   #EMBI:Emerald.Bioscience.Announces.$2.0.Million.Registered.Direct.Offering...:-} captainscotty 11/25/19 09:31:21 AM
#5787   #EMBI: TWEET...TWEET...:-} captainscotty 11/25/19 09:05:21 AM
PostSubject